// App-Quantinova.ai

4907 : Targeting Aurora Kinases in Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Hui-Ju Lin

Principal Investigators

  • Kung-Chao Chang

  • Jiann-Shiuh Chen

  • Ming-Ying Tsai

  • Liang-Yi Hung

  • Tsai-Yun Chen

Medical Centers

  • Division of Hematology-Oncology, Department of Internal Medicine, National Cheng-Kung University, Medical College and Hospital, Tainan, Taiwan

  • Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan

Locations

  • Taiwan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Hematological malignancies

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

  • Cyclin dependent kinase inhibitor 1A

Drug/Treatment

  • Tozasertib

  • VE-465

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved